LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

Home・Aandelen Lijst・CorMedix Inc

CorMedix Inc

Gesloten

SectorGezondheidszorg

12.53 2.96

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

12.03

Max

12.6

Belangrijke statistieken
By Trading Economics
Inkomsten	89M 109M
Verkoop	65M 104M
K/W Sectorgemiddelde	5.606 78.892
EPS	0.28
Winstmarge	104.112
Werknemers	64
EBITDA	37M 57M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+43.56% upside

Dividenden
By Dow Jones
Volgende Winsten	24 mrt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	108M 976M
Vorige openingsprijs	9.57
Vorige sluitingsprijs	12.53

Nieuwssentiment

By Acuity

23%

77%

47 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

9.2 / N/A Steun & Weerstand

CorMedix Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 dec 2025, 21:41 UTC

Acquisities, Fusies, Overnames

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

26 dec 2025, 20:22 UTC

Marktinformatie

Oil Loses Ground On Russia-Ukraine Peace Efforts -- Market Talk

26 dec 2025, 20:13 UTC

Marktinformatie

U.S. Natural Gas Gains on Colder Weather Outlook -- Market Talk

26 dec 2025, 19:24 UTC

Acquisities, Fusies, Overnames

Nvidia's Groq Deal Is an Instagram Moment -- With 1 Big Risk -- Barrons.com

26 dec 2025, 17:45 UTC

Marktinformatie

U.S. Diesel Down on Lower Crude Prices, Freight-Sector Lull -- Market Talk

26 dec 2025, 15:52 UTC

Marktinformatie

Oil Futures Turn Lower After Steady Start -- Market Talk

26 dec 2025, 14:58 UTC

Marktinformatie

Silver, Gold Reach New Highs Amid Geopolitical Tension -- Market Talk

26 dec 2025, 14:41 UTC

Marktinformatie

U.S. Natural Gas Futures Look to End Week Higher -- Market Talk

26 dec 2025, 14:28 UTC

Marktinformatie

Dollar Indexes Flat as Yen Rally Wanes -- Market Talk

26 dec 2025, 13:47 UTC

Marktinformatie

Oil Futures Steady in Thin Holiday Trade -- Market Talk

26 dec 2025, 07:22 UTC

Marktinformatie

Comex Gold Futures' Strong Bullish Momentum in Play, Chart Shows -- Market Talk

26 dec 2025, 05:03 UTC

Marktinformatie

Malaysian Ringgit Likely to Face Pressure From Dollar Strength in 1Q -- Market Talk

26 dec 2025, 03:38 UTC

Marktinformatie

Global Equities Roundup: Market Talk

26 dec 2025, 03:38 UTC

Marktinformatie

Korean Won Strengthens, Supported by Verbal Interventions -- Market Talk

26 dec 2025, 02:44 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

26 dec 2025, 02:44 UTC

Marktinformatie

Singapore Dollar Weakens Slightly on Likely Position Adjustments -- Market Talk

26 dec 2025, 01:39 UTC

Marktinformatie

China's Central Bank Signals Possibility of Easing Policy in Coming Months -- Market Talk

26 dec 2025, 01:14 UTC

Marktinformatie

Oil Edges Higher Amid Geopolitical Tensions -- Market Talk

26 dec 2025, 00:34 UTC

Marktinformatie

Yen Mostly Weakens Amid Risk-on Sentiment -- Market Talk

26 dec 2025, 00:15 UTC

Marktinformatie

Nikkei Gains 0.6%, Led by Tech, Videogame Stocks -- Market Talk

25 dec 2025, 23:42 UTC

Marktinformatie

Nikkei May Trade in Range; Yen in Focus -- Market Talk

25 dec 2025, 23:40 UTC

Marktinformatie

Gold Edges Higher Amid Geopolitical Risks -- Market Talk

25 dec 2025, 00:20 UTC

Acquisities, Fusies, Overnames

Nike Climb Boosts Dow, S&P 500 -- 2nd Update

24 dec 2025, 22:22 UTC

Acquisities, Fusies, Overnames

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

24 dec 2025, 21:26 UTC

Acquisities, Fusies, Overnames

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

24 dec 2025, 19:35 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

24 dec 2025, 19:35 UTC

Marktinformatie

Treasury Yields Decline Ahead of Christmas -- Market Talk

24 dec 2025, 19:09 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Global Equities Roundup: Market Talk

24 dec 2025, 19:09 UTC

Marktinformatie

Acquisities, Fusies, Overnames

ServiceNow's Armis Acquisition Shouldn't Fuel Fears That Seat-Based Model Threatened -- Market Talk

24 dec 2025, 19:06 UTC

Marktinformatie

Oil Futures Little Changed in Light Pre-Holiday Trade -- Market Talk

Peer Vergelijking

Prijswijziging

CorMedix Inc Prognose

Koersdoel

By TipRanks

43.56% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 17.5 USD 43.56%

Hoogste 22 USD

Laagste 14 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor CorMedix Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

6 ratings

Buy

Hold

Sell

Gebaseerd op 6 analisten die aandelenratings hebben gegeven aan CorMedix Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

9.2 / N/ASteun & Weerstand

Recent bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

47 / 374 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.